Lipoxin A<sub>4</sub>/FPR2 Signaling Mitigates Ferroptosis of Alveolar Epithelial Cells via NRF2-Dependent Pathway During Lung Ischemia-Reperfusion Injury. [PDF]
Kollareth DJM +9 more
europepmc +1 more source
Exercise Remodels Akkermansia-Associated Eicosanoid Metabolism to Alleviate Intestinal Senescence: Multi-Omics Insights. [PDF]
Yu C +8 more
europepmc +1 more source
Erratum: "Dysregulation of lipid mediators in patients with frequent exacerbations of COPD" Marie Fisk, Esteban A. Gomez, Yuan Sun, Monika Mickute, Carmel McEniery, John R. Cockcroft, Charlotte Bolton, Jonathan Fuld, Joseph Cheriyan, Yasmin, William MacNee, Ruth Tal-Singer, Michael Polkey, Ian Wilkinson and Jesmond Dalli. <i>ERJ Open Res</i> 2025; 11: 00950-2023. [PDF]
europepmc +1 more source
Editorial expression of concern: Lipoxin A4 analogue, BML-111, reduces platelet activation and protects from thrombosis. [PDF]
AlOmar S, Mitchell JL, AlZahrani E.
europepmc +1 more source
<i>Lacticaseibacillus rhamnosus</i> B6 alleviates metabolic dysfunction-associated fatty liver disease by suppressing intestinal LPS synthesis and regulating lipid metabolism. [PDF]
Wang D +5 more
europepmc +1 more source
Effects of specialized proresolving mediators on gut epithelial barrier in early life. [PDF]
Chen J +10 more
europepmc +1 more source
Lipoxin A4 improves myocardial ischemia/reperfusion injury through the Notch1-Nrf2 signaling pathway. [PDF]
Yan X +10 more
europepmc +1 more source
From lipid switch to tissue repair: how resolvins reprogram macrophage polarization and function. [PDF]
Buete R, Scherer J, Patsalos A, Nagy L.
europepmc +1 more source
Lipoxin A4 improves cardiac remodeling and function in diabetes-associated cardiac dysfunction. [PDF]
Fu T +14 more
europepmc +1 more source

